A detailed history of Td Private Client Wealth LLC transactions in Repligen Corp stock. As of the latest transaction made, Td Private Client Wealth LLC holds 186 shares of RGEN stock, worth $27,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186
Previous 127 46.46%
Holding current value
$27,070
Previous $16 Million 72.9%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$119.79 - $167.35 $7,067 - $9,873
59 Added 46.46%
186 $27.7 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $15,240 - $23,234
127 New
127 $16 Million
Q1 2024

Aug 16, 2024

BUY
$170.78 - $208.42 $4,952 - $6,044
29 Added 27.88%
133 $24.5 Million
Q4 2023

Aug 16, 2024

SELL
$114.17 - $185.35 $1,255 - $2,038
-11 Reduced 9.57%
104 $18.7 Million
Q3 2023

Aug 16, 2024

BUY
$138.78 - $176.51 $13,739 - $17,474
99 Added 618.75%
115 $18.3 Million
Q1 2023

Aug 16, 2024

SELL
$154.26 - $198.1 $15,888 - $20,404
-103 Reduced 86.55%
16 $2.69 Million
Q4 2022

Aug 16, 2024

SELL
$162.42 - $220.56 $324 - $441
-2 Reduced 1.65%
119 $20.1 Million
Q3 2022

Aug 16, 2024

SELL
$160.42 - $256.21 $1,443 - $2,305
-9 Reduced 6.92%
121 $22.6 Million
Q2 2022

Aug 16, 2024

BUY
$140.68 - $188.02 $2,250 - $3,008
16 Added 14.04%
130 $21.1 Million
Q1 2022

Aug 16, 2024

SELL
$161.19 - $257.96 $5,802 - $9,286
-36 Reduced 24.0%
114 $21.4 Million
Q4 2021

Aug 16, 2024

SELL
$247.59 - $304.47 $38,624 - $47,497
-156 Reduced 50.98%
150 $39.7 Million
Q3 2021

Aug 16, 2024

BUY
$194.77 - $324.21 $34,863 - $58,033
179 Added 140.94%
306 $88.4 Million
Q3 2020

Aug 16, 2024

BUY
$122.51 - $158.27 $1,592 - $2,057
13 Added 260.0%
18 $2.66 Million
Q2 2020

Aug 16, 2024

SELL
$94.33 - $140.48 $11,508 - $17,138
-122 Reduced 96.06%
5 $618,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.08B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.